1. Wang, Tao, Dai, Liqun, Shen, Shu, Qiu, Yiwen, Wang, Wentao. 2022. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm. In Frontiers in immunology, 13, 843408. doi:10.3389/fimmu.2022.843408. https://pubmed.ncbi.nlm.nih.gov/35693827/
2. Obinata, Daisuke, Funakoshi, Daigo, Takayama, Kenichi, Takahashi, Satoru, Inoue, Satoshi. 2022. OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer. In Scientific reports, 12, 6094. doi:10.1038/s41598-022-10099-x. https://pubmed.ncbi.nlm.nih.gov/35413990/
3. Guo, Qianqian, Zhou, Yi, Ni, Haiwei, Zheng, Lufeng, Zhang, Wenzhou. 2024. The SIX2/PFN2 feedback loop promotes the stemness of gastric cancer cells. In Journal of translational medicine, 22, 832. doi:10.1186/s12967-024-05618-5. https://pubmed.ncbi.nlm.nih.gov/39256760/
4. Liu, Jiyuan, Wu, Yunlong, Wang, Qizhang, Liao, Xuejuan, Pan, Jian. 2018. Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma. In Future oncology (London, England), 14, 449-459. doi:10.2217/fon-2017-0348. https://pubmed.ncbi.nlm.nih.gov/29322815/
5. Yan, Jiliang, Ma, Chunyan, Gao, Yue. 2017. MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines. In Oncology reports, 37, 3146-3154. doi:10.3892/or.2017.5566. https://pubmed.ncbi.nlm.nih.gov/28405690/
6. Asai, Shunichi, Koma, Ayaka, Nohata, Nijiro, Hanazawa, Toyoyuki, Seki, Naohiko. 2022. Impact of miR-1/miR-133 Clustered miRNAs: PFN2 Facilitates Malignant Phenotypes in Head and Neck Squamous Cell Carcinoma. In Biomedicines, 10, . doi:10.3390/biomedicines10030663. https://pubmed.ncbi.nlm.nih.gov/35327465/
7. Lu, Lihong, Zhong, Ziwen, Gu, Jiahui, Zhu, Minmin, Miao, Changhong. 2021. ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy. In Molecular medicine (Cambridge, Mass.), 27, 74. doi:10.1186/s10020-021-00339-7. https://pubmed.ncbi.nlm.nih.gov/34238215/